Canonical pathways
Compares your data with expert-curated signalling and metabolic pathways and predicts which of them are activated or inhibited.
Pathway analysis · curated knowledge base
QIAGEN IPA is a platform for the analysis and biological interpretation of omics data, using an expert-curated database of genes, biological pathways, regulators and molecular interactions. It helps explain which biological processes and regulatory mechanisms lie behind the changes observed in the analysed data.
IPA is a platform for the downstream biological interpretation of omics experiment results. It works with lists of genes, proteins or metabolites and connects them to biological pathways, regulators, diseases and drugs. In this way, it helps answer the question of what may lie behind the changes observed in the analysed data.
QIAGEN has been building the IPA database and software for more than 25 years. Clinical and scientific experts continuously review the published literature and record experimentally supported relationships between molecules. Computational models of biological pathways and their interactions then run on top of this database.
IPA works with RNA-seq, proteomics, phosphoproteomics, metabolomics and microarray data. Even a simple list of genes or molecules is enough for an analysis.
Compares your data with expert-curated signalling and metabolic pathways and predicts which of them are activated or inhibited.
Identifies transcription factors, kinases, drugs and other regulators that may explain the observed changes in the data.
Builds hierarchical regulatory networks and identifies master regulators acting through downstream regulatory cascades.
Shows which biological functions, diseases and toxicological processes may be affected in the analysed data.
Compares several experiments at once and shows the differences in predicted pathways and biological processes.
Compares your result with more than 250,000 publicly available omics datasets and finds similar profiles.
The content is based on expert review of original publications, not just on automated text mining. Individual relationships are supported by experimental data.
IPA does not just determine whether a given pathway or function is affected. It also predicts whether it is activated or inhibited.
Analyses can be run in a graphical interface without writing code. The outputs can be used directly in presentations or publications.
RNA-seq, proteomics, phosphoproteomics, metabolomics and microarray data in a single analysis environment.
Your own results can be compared with a large collection of public datasets to see whether they match known biological patterns or differ from them.
IPA has been cited in tens of thousands of scientific publications, including papers in Nature, Cell, Science and PNAS.
An assistant built directly into IPA Desktop. It answers biological questions, explains results and carries out further analysis steps on request.
A web interface with AI-generated summaries. Results can be shared, and visualisations can be customised for presentations or publications.
The predicted activity of biological pathways, regulators and functions can be displayed directly at the level of individual cells.
Identification of therapeutic targets, elucidation of mechanisms of action and prediction of adverse effects from transcriptomic data.
Analysis of biological pathways and regulators associated with a tumour phenotype, and identification of candidate biomarkers.
Linking results from model systems to patient samples and comparing biological patterns across datasets.
Analysis of toxicological functions and biological pathways in safety studies, including phosphoproteomic data.
Biological interpretation of single-cell data at the level of individual cells and cell populations.
Analysis of microRNAs, their target genes and their links to measured gene expression.
We would be happy to demonstrate IPA on your own data, walk you through the analysis types and arrange trial access and training.